Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TRICOS T RESORBABLE BONE SUBSTITUTE

K-Number: K073571 · 2008-04-08

ApplicantBaxter Healthcare Corporation
Decision Date2008-04-08
Product CodeLYC
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

TRICOS T RESORBABLE BONE SUBSTITUTE is the device name listed in this FDA 510(k) record. The listed applicant is Baxter Healthcare Corporation. It received FDA 510(k) clearance on 2008-04-08 under 510(k) number K073571. The device is classified under product code LYC. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TRICOS T RESORBABLE BONE SUBSTITUTE?

TRICOS T RESORBABLE BONE SUBSTITUTE is a medical device that received FDA 510(k) clearance on 2008-04-08. The listed applicant is Baxter Healthcare Corporation. The 510(k) number is K073571.

When did TRICOS T RESORBABLE BONE SUBSTITUTE receive FDA 510(k) clearance?

TRICOS T RESORBABLE BONE SUBSTITUTE received FDA 510(k) clearance on 2008-04-08, under 510(k) number K073571.

Who is the listed applicant for TRICOS T RESORBABLE BONE SUBSTITUTE?

The FDA 510(k) record lists Baxter Healthcare Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TRICOS T RESORBABLE BONE SUBSTITUTE?

The FDA product code for TRICOS T RESORBABLE BONE SUBSTITUTE is LYC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Baxter Healthcare Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K251745Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs)K251640SIGMA Spectrum Infusion Pump with Master Drug LibraryK251636Spectrum IQ Infusion System with Dose IQ Safety Software (3570009)K243529Solution Administration SetsK242339Intravascular Extension Sets and AccessoriesK242390Novum IQ Syringe Pump (40800BAXUS)

View all 54 devices →

Related Devices (Code: LYC)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K253317Cytrans™ ElashieldGC America, Inc.K253883Bonalive MaxillofacialBonalive , Ltd.K251818BONTREE PLUSHudens Bio Co., Ltd.K244006FG Bone Graft MFull Golden Biotech Co., Ltd.K243745FG Bone Graft BFull Golden Biotech CorporationK241186Synthetic Bone Graft ParticulateShenzhen Dazhou Medical Technology Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑